Market Tracker

03/27 10:36am ET
275.45
BATS BZX Real-Time Price
As of 10:35am ET
 +0.63 / +0.23%
Today’s Change
205.42
Today|||52-Week Range
307.33
+5.45%
Year-to-Date
Stock Market News for March 24, 2017
Mar 24 / Zacks.com - Paid Partner Content
Alkermes Starts Phase III Study to Treat Multiple Sclerosis
Mar 17 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Amgen Down on Repatha Data, Nektar Surges on Pain Results
Mar 22 / Zacks.com - Paid Partner Content
Stock Market News for March 17, 2017
Mar 17 / Zacks.com - Paid Partner Content
Five Stocks I Like on the Nasdaq Market
Mar 21 / GuruFocus News - Paid Partner Content
Acorda's Four Ampyra Patents Upheld by PTAB, Shares Rise
Mar 13 / Zacks.com - Paid Partner Content
3 Biotech Stocks That Are Broker Favorites
Mar 21 / Zacks.com - Paid Partner Content
Trump vows to bring drug prices 'way down'
Mar 07 / CNNMoney.com
Trump, Biogen and Amgen Hammer Healthcare ETFs
Mar 20 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close274.82
Today’s open272.62
Day’s range272.31 - 276.38
Volume13,490
Average volume (3 months)1,776,538
Market cap$59.3B
Dividend yield--
Data as of 10:35am ET, 03/27/2017

Growth & Valuation

Earnings growth (last year)+10.32%
Earnings growth (this year)+3.58%
Earnings growth (next 5 years)+8.72%
Revenue growth (last year)+9.37%
P/E ratio17.7
Price/Sales6.09
Price/Book4.89

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences+0.17+0.25%
ILMNIllumina Inc-0.06-0.04%
BIVVBioverativ Inc+0.03+0.06%
KITEKite Pharma Inc+0.77+1.00%
Data as of 10:35am ET, 03/27/2017

Financials

Next reporting dateApril 27, 2017
EPS forecast (this quarter)$5.00
Annual revenue (last year)$10.2B
Annual profit (last year)$3.7B
Net profit margin36.32%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Michel Vounatsos
Chief Financial Officer &
Executive Vice President
Paul J. Clancy
Corporate headquarters
Cambridge, Massachusetts

Forecasts